![Avinoam Kadouri](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Avinoam Kadouri
Corporate Officer/Principal bei Weizmann Institute of Science
Aktive Positionen von Avinoam Kadouri
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Weizmann Institute of Science | Corporate Officer/Principal | - | - |
Karriereverlauf von Avinoam Kadouri
Ehemalige bekannte Positionen von Avinoam Kadouri
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BONUS BIOGROUP LTD. | Technik-/Wissenschafts-/F&E-Leiter | 04.10.1981 | 01.09.2016 |
Gründer | 04.10.1981 | 01.09.2016 | |
The European Association for Bioindustries | Vorsitzender | - | - |
Animal Cell Technology Industrial Platform | Vorsitzender | - | - |
Serono International SA | Corporate Officer/Principal | - | - |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Technik-/Wissenschafts-/F&E-Leiter | 28.07.2009 | - |
Corporate Officer/Principal | - | 28.07.2009 | |
Uni Targeting Research AS
![]() Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Statistik
International
Vereinigte Staaten | 3 |
Israel | 3 |
Norwegen | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Chairman | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BONUS BIOGROUP LTD. | Health Technology |
Private Unternehmen | 5 |
---|---|
Uni Targeting Research AS
![]() Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Health Technology |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Serono International SA | |
Animal Cell Technology Industrial Platform | |
The European Association for Bioindustries |
- Börse
- Insiders
- Avinoam Kadouri
- Erfahrung